Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This study will determine the maximum dose of KW-2450 that can be administered safely to
subjects with advanced previously treated solid tumor and evaluate its effectiveness.